BERTOLOTTI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 28.072
AS - Asia 13.058
EU - Europa 12.498
SA - Sud America 1.774
Continente sconosciuto - Info sul continente non disponibili 341
AF - Africa 259
OC - Oceania 32
Totale 56.034
Nazione #
US - Stati Uniti d'America 27.498
SG - Singapore 4.146
IT - Italia 3.667
CN - Cina 3.504
GB - Regno Unito 3.135
HK - Hong Kong 1.573
BR - Brasile 1.313
VN - Vietnam 1.232
DE - Germania 1.030
SE - Svezia 955
FI - Finlandia 783
BD - Bangladesh 632
UA - Ucraina 590
FR - Francia 535
TR - Turchia 482
RU - Federazione Russa 463
PL - Polonia 388
CA - Canada 345
KR - Corea 328
IN - India 248
BG - Bulgaria 228
NL - Olanda 210
ID - Indonesia 168
AR - Argentina 167
IQ - Iraq 104
JP - Giappone 104
MX - Messico 95
ES - Italia 87
IE - Irlanda 73
EC - Ecuador 70
PK - Pakistan 60
ZA - Sudafrica 59
BE - Belgio 54
AE - Emirati Arabi Uniti 53
VE - Venezuela 53
CO - Colombia 52
AT - Austria 51
MA - Marocco 50
MY - Malesia 49
CL - Cile 46
PH - Filippine 45
UZ - Uzbekistan 43
TW - Taiwan 42
CH - Svizzera 38
SA - Arabia Saudita 36
CZ - Repubblica Ceca 32
IR - Iran 29
CR - Costa Rica 27
AU - Australia 26
JO - Giordania 25
LT - Lituania 25
PE - Perù 25
TH - Thailandia 25
ET - Etiopia 24
EG - Egitto 23
DZ - Algeria 21
PY - Paraguay 21
JM - Giamaica 20
GR - Grecia 19
RO - Romania 19
TN - Tunisia 19
KE - Kenya 16
UY - Uruguay 16
NP - Nepal 15
OM - Oman 15
TT - Trinidad e Tobago 15
HN - Honduras 13
PT - Portogallo 13
AZ - Azerbaigian 11
BY - Bielorussia 11
IL - Israele 11
PA - Panama 11
SI - Slovenia 11
BO - Bolivia 10
NI - Nicaragua 10
GT - Guatemala 9
MK - Macedonia 9
NG - Nigeria 9
RS - Serbia 9
DO - Repubblica Dominicana 8
EU - Europa 8
SC - Seychelles 8
SK - Slovacchia (Repubblica Slovacca) 8
SY - Repubblica araba siriana 8
AL - Albania 7
BH - Bahrain 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LU - Lussemburgo 7
MD - Moldavia 7
PS - Palestinian Territory 7
DK - Danimarca 6
HU - Ungheria 6
KW - Kuwait 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
PR - Porto Rico 6
SN - Senegal 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
Totale 55.619
Città #
Singapore 2.787
Ashburn 2.466
Santa Clara 2.456
Fairfield 2.379
Southend 2.013
Hong Kong 1.549
Woodbridge 1.496
Chandler 1.322
Houston 1.318
San Jose 1.100
Jacksonville 1.044
Hefei 984
Seattle 894
Dearborn 830
Wilmington 827
Ann Arbor 820
Cambridge 788
Beijing 637
Council Bluffs 600
Helsinki 577
London 573
Chicago 572
Nyköping 571
Los Angeles 537
Ho Chi Minh City 404
Modena 387
Warsaw 370
New York 339
Milan 320
Seoul 315
The Dalles 305
San Diego 299
Hanoi 281
Izmir 278
Princeton 242
Sofia 216
Salt Lake City 197
Eugene 187
Lauterbourg 186
Buffalo 180
Shanghai 165
Rome 161
Moscow 143
Dallas 132
Munich 131
Boardman 129
São Paulo 125
Columbus 123
Bologna 119
Tampa 117
Toronto 113
Elk Grove Village 111
Des Moines 108
Jakarta 104
Fremont 83
Orem 80
Tokyo 79
Frankfurt am Main 75
Redwood City 75
Guangzhou 71
Dublin 64
Haiphong 62
Brooklyn 58
Bremen 57
Grafing 57
Phoenix 56
Da Nang 55
Falls Church 54
Montreal 53
Naples 53
Sterling 53
Baghdad 49
Florence 49
Denver 46
Brussels 44
Parma 43
Atlanta 42
North York 40
Turin 40
Turku 40
Lancaster 39
San Francisco 39
San Mateo 39
Nuremberg 38
Amsterdam 36
Miami 36
Manchester 35
Mountain View 35
Boston 34
Chennai 34
Kunming 34
Tashkent 34
Norwalk 33
Kent 32
Nanjing 32
Padova 32
Mexico City 31
North Bergen 31
Broomfield 30
Washington 30
Totale 37.589
Nome #
MoCA 7.1: Multicenter Validation of the First Italian Version of Montreal Cognitive Assessment 1.165
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 726
17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures 471
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 461
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors 456
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 444
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 439
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 435
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 413
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 413
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 408
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 399
APOE MODENA : A NOVEL APOE MUTANT CAUSING LIPOPROTEIN GLOMERULOPATHY 387
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 387
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 384
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 381
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 380
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 379
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 376
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 375
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 375
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 370
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 368
Serum time course of naltrexone and 6 beta-naltrexol levels during long term treatment in drug addicts 367
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 367
Physical exercise for late life depression: effects on cognition and disability 365
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 364
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 361
Telomere length elongation after weight loss intervention in obese adults 349
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 348
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 347
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 346
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 346
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 345
Endocrine and liver interaction: the role of endocrine pathways in NASH 344
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 341
Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report 336
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study 333
Effects of cholecalciferol supplementation in patients with stable heart failure and low vitamin D levels (ECSPLOIT-D). A double-blind, randomized, placebo-controlled pilot study 332
Analgesic drug taking: Beliefs and behavior among headache patients 332
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 331
The relationship between age and fat infiltration in liver and muscle 331
Nonalcoholic fatty liver disease and aging: epidemiology to management 328
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 326
Bile acids and nonalcoholic fatty liver disease: An intriguing relationship 325
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 323
La clinica metabolica per il trattamento della lipodistrofia 322
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 319
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e 317
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 313
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 312
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 311
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 311
Review article: effect of bile salt pool composition on hepatic and biliary functions 308
Risk of birth defects associated with maternal pregestational diabetes. 307
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 302
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 300
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 300
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 299
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 296
Predictive factors of lack of response to antiviral therapy among in patients with recurrent hepatitis C after liver transplantation. 294
Disposition of naproxen after oral administration during and between migraine attacks. 293
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials 293
Advances in the comprehension of the pathophysiology of bile secretion 292
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 292
Effects of acute changes of bile acid pool composition on biliary lipid secretion 288
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 285
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 285
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 284
Olanzapine metabolic side effects: a weight gain issue? 284
Liver X receptors and copper metabolism: New frontiers for the oxysterol receptors 281
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 279
Bile acid structure and regulation of biliary protein secretion and composition in man 276
Effect of ursocholic acid on bile lipid secretion and composition 275
Anatomia e fisiologia delle vie biliari 274
Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention 274
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 272
Case of an old man with aortic dissection type A and enlarging meningioma 272
The use of stable and radioactive sterol tracers as a tool to investigate cholesterol degradation to bile acids in humans in vivo 270
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 269
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 269
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 268
Nonalcoholic fatty liver disease induced by leuprorelin acetate 267
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 266
Review article: hyperlipidaemia and cardiovascular risk 264
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 260
Hypertensive disease in the elderly: Predictors of clinical evolution in a follow-up study 257
REGULATION OF HEPATIC CHOLESTEROL-METABOLISM IN THE RAT IN-VIVO. EFFECT OF A SYNTHETIC FAT-FREE DIET ON STEROL SYNTHESIS AND LOW-DENSITY-LIPOPROTEIN TRANSPORT 256
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 256
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards 254
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 254
Influence of age and sex on serum concentrations of total dimeric activin A 253
Drug-Induced Liver Injury - Types and Phenotypes 253
Risk communication at the time of Coronavirus: are we washing our hand of COVID-19? 253
PHARMACOKINETICS OF TIAPROFENIC ACID AFTER ORAL-ADMINISTRATION IN FASTING PATIENTS DURING AND BETWEEN MIGRAINE ATTACKS 252
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 252
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 250
Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy 250
Changes in cholesterol homeostasis associated with aging and with age-related conditions: pathophysiological and clinical implications 247
Heart failure and chronic kidney disease in a registry of internal medicine wards 247
Totale 33.356
Categoria #
all - tutte 216.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 216.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.715 0 0 311 389 101 218 314 266 552 243 808 513
2022/20233.991 417 361 312 350 448 576 102 430 510 74 218 193
2023/20242.853 128 163 184 271 527 231 366 339 103 111 135 295
2024/20258.969 320 152 215 638 1.816 1.277 587 444 876 449 972 1.223
2025/202618.278 996 697 1.426 2.152 3.209 1.669 1.946 842 1.671 1.423 1.316 931
2026/20271.926 656 1.172 98 0 0 0 0 0 0 0 0 0
Totale 56.034